Evaluation of ureteral injuries caused by ureteral access sheath insertion during ureteroscopic lithotripsy.


Journal

International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237

Informations de publication

Date de publication:
06 2023
Historique:
received: 17 10 2022
accepted: 26 02 2023
medline: 6 6 2023
pubmed: 26 3 2023
entrez: 25 3 2023
Statut: ppublish

Résumé

To evaluate ureteral injuries caused by insertion of a 13-Fr ureteral access sheath and identify factors (other than pre-stenting) that are predictive of ureteral injury. We enrolled 201 patients who underwent ureteroscopic lithotripsy (URSL). We excluded 80 patients who underwent ureteral stent insertion before URSL, 10 patients who did not use a ureteral access sheath, and 2 patients in whom a ureteral access sheath could not be inserted. In total, 109 patients were analyzed; all underwent insertion of a 13-Fr ureteral access sheath. We investigated ureteral injuries using the Traxer ureteral injury scale. There were 21 (19.3%) cases of ureteral access sheath-related ureteral injury, including 11 (10.1%) grade 2 cases and 10 (9.2%) grade 3 cases. The ureteral injury location was the proximal ureter in 20 cases (18.3%), middle ureter in one case (0.9%), and distal ureter in zero cases. Multiple logistic regression analysis showed that male sex and smaller stone diameter were significant predictive factors for ureteral injury (p = 0.037, odds ratio [OR]: 5.19, 95% confidence interval [CI]: 1.11-24.3 and p = 0.02, OR: 0.83, 95% CI: 0.71-0.97, respectively). Postoperative ureteral stricture did not occur in any cases. The rate of ureteral injury caused by a 13-Fr ureteral access sheath was considerable, and most ureteral injuries occurred in the proximal ureter. Male sex and smaller stone diameter were significant predictive factors for ureteral injury. The proximal ureter should be confirmed when using a 13-Fr ureteral access sheath, particularly in male patients and patients with small stones.

Identifiants

pubmed: 36964958
doi: 10.1111/iju.15176
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

554-558

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 The Japanese Urological Association.

Références

Kourambas J, Byrne RR, Preminger GM. Does a ureteral access sheath facilitate ureteroscopy? J Urol. 2001;165:789-93.
L'Esperance JO, Ekeruo WO, Scales CD Jr, Marguet CG, Springhart WP, Maloney ME. Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi. Urology. 2005;66:252-5.
Stern JM, Yiee J, Park S. Safety and efficacy of ureteral access sheaths. J Endourol. 2007;21:119-23.
Loftus CJ, Ganesan V, Traxer O, Schold JD, Noble M, Sivalingam S, et al. Ureteral Wall injury with ureteral access sheaths: a randomized prospective trial. J Endourol. 2020;34:932-6.
Zelenko N, Coll D, Rosenfeld AT, Smith RC. Normal ureter size on unenhanced helical CT. AJR Am J Roentgenol. 2004;182:1039-41.
Traxer O, Thomas A. Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery. J Urol. 2013;189:580-4.
Vanlangendonck R, Landman J. Ureteral access strategies: pro-access sheath. Urol Clin North Am. 2004;31:71-81.
Abrahams HM, Stoller ML. The argument against the routine use of ureteral access sheaths. Urol Clin North Am. 2004;31:83-7.
Lallas CD, Auge BK, Raj GV, Santa-Cruz R, Madden JF, Preminger GM. Laser doppler flowmetric determination of ureteral blood flow after ureteral access sheath placement. J Endourol. 2002;16:583-90.
Breda A, Ogunyemi O, Leppert JT, Schulam PG. Flexible ureteroscopy and laser lithotripsy for multiple unilateral intrarenal stones. Eur Urol. 2009;55:1190-6.
Breda A, Territo A, López-Martínez JM. Benefits and risks of ureteral access sheaths for retrograde renal access. Curr Opin Urol. 2016;26:70-5.
Tracy CR, Ghareeb GM, Paul CJ, Brooks NA. Increasing the size of ureteral access sheath during retrograde intrarenal surgery improves surgical efficiency without increasing complications. World J Urol. 2018;36:971-8.
Tefik T, Buttice S, Somani B, Erdem S, Oktar T, Özcan F, et al. Impact of ureteral access sheath force of insertion on ureteral trauma: in vivo preliminary study with 7 patients. Ulus Travma Acil Cerrahi Derg. 2018;24:514-20.
Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG. Characterization of urinary symptoms in patients with ureteral stents. Urology. 2002;59:511-9.
Taguchi M, Yoshida K, Sugi M, Kinoshita H, Matsuda T. Effect of ureteral stent diameter on ureteral stent-related symptoms. Low Urin Tract Symptoms. 2019;11:195-9.
Taguchi M, Yoshida K, Sugi M, Matsuda T, Kinoshita H. A ureteral stent crossing the bladder midline leads to worse urinary symptoms. Cent European J Urol. 2017;70:412-7.
Taguchi M, Inoue T, Muguruma K, Murota T, Kinoshita H, Matsuda T. Impact of loop-tail ureteral stents on ureteral stent-related symptoms immediately after ureteroscopic lithotripsy: comparison with pigtail ureteral stents. Investig Clin Urol. 2017;58:440-6.
Koo KC, Yoon JH, Park NC, Lee HS, Ahn HK, Lee KS, et al. The impact of preoperative alpha-adrenergic antagonists on ureteral access sheath insertion force and the upper limit of force required to avoid ureteral mucosal injury: a randomized controlled study. J Urol. 2018;199:1622-30.
Reed AM, Christensen CL, Allam CL. Duration of ureteral stenting following Ureteroscopic perforation in a porcine model. J Endourol. 2021;35:259-65.

Auteurs

Makoto Taguchi (M)

Department of Urology, Osaka Saiseikai Izuo Hospital Based on Social Welfare Organization "Saiseikai" Imperial Gift Foundation Inc., Osaka, Japan.
Department of Urology and Andrology, Kansai Medical University, Osaka, Japan.

Kaneki Yasuda (K)

Department of Urology, Osaka Saiseikai Izuo Hospital Based on Social Welfare Organization "Saiseikai" Imperial Gift Foundation Inc., Osaka, Japan.

Hidefumi Kinoshita (H)

Department of Urology and Andrology, Kansai Medical University, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH